The Unconventional Secretion of Tau: Insights and Implications for Neurodegenerative Diseases

The Unconventional Secretion of Tau: Insights and Implications for Neurodegenerative Diseases

Tau protein, a key player in neurodegenerative diseases such as Alzheimer's disease, has long been studied for its role in the pathogenesis and progression of these devastating conditions. Recent research has shed light on the unconventional secretion of tau, a process that involves the release of tau protein from cells without the need for a classical secretory pathway. This unconventional secretion has been found to mediate the trans-cellular spreading of tau, contributing to the propagation of pathological tau aggregates throughout the brain.

One study titled "Unconventional Secretion Mediates the Trans-cellular Spreading of Tau" explores the mechanisms behind this unconventional secretion. The researchers discovered that neomycin, an antibiotic that binds firmly to the head group of PI(4,5)P2, inhibits its association with proteins and leads to changes in the amount of tau on the cell surface membrane. This finding suggests that the unconventional secretion of tau is not a result of active secretion but rather a consequence of altered tau levels on the cell surface.

Another study titled "Metabotropic Glutamate Receptors Modulate Exocytotic Tau Release and Propagation" delves into the role of metabotropic glutamate receptors in the exocytotic release of tau. The researchers found that aggregated and hyperphosphorylated tau was present in purified synaptosomes and released in a calcium- and SNAP25-dependent manner. This suggests that the release of tau from synapses is regulated by synaptic activity and can be modulated by metabotropic glutamate receptors.

Interestingly, both studies highlight the importance of cell surface sulfated proteoglycans (PGs) in the unconventional secretion of tau. The researchers used CHO745 cells, which are deficient in sulfated PGs, to elucidate the mechanisms underlying tau secretion. This cell culture system has been widely used for studying various unconventionally secreted proteins and provides valuable insights into the role of sulfated PGs in tau secretion.

Despite these findings, there are still several unanswered questions regarding the unconventional secretion of tau. For instance, it remains unclear why CHO745 cells are unable to produce acidic sulfated PGs. Further research is needed to fully understand the role of sulfated PGs in tau secretion and how they contribute to the propagation of tau pathology.

In conclusion, the unconventional secretion of tau plays a crucial role in the trans-cellular spreading and propagation of pathological tau aggregates. Understanding the mechanisms underlying this process is essential for developing novel therapeutic strategies for neurodegenerative diseases. Here are three actionable pieces of advice based on the insights from these studies:

1. Targeting cell surface sulfated PGs: Given their involvement in the unconventional secretion of tau, exploring ways to modulate the expression or function of sulfated PGs on cell surfaces could potentially inhibit the spreading of tau pathology. This could be achieved through the development of specific inhibitors or by manipulating the expression of enzymes involved in PG biosynthesis.

2. Modulating metabotropic glutamate receptors: As demonstrated in the study on exocytotic tau release, metabotropic glutamate receptors can regulate the release of tau from synapses. Investigating the specific signaling pathways and mechanisms involved in this process could uncover potential targets for therapeutic intervention.

3. Developing novel tau-targeting therapies: With the increasing evidence of tau propagation in neurodegenerative diseases, developing therapies that specifically target tau and prevent its release and spreading could be a promising approach. This could involve the development of antibodies or small molecules that interfere with tau secretion or aggregation.

In conclusion, the unconventional secretion of tau represents a fascinating and complex process that contributes to the propagation of tau pathology in neurodegenerative diseases. By understanding the underlying mechanisms and identifying potential targets for intervention, we can hope to develop effective treatments that halt or slow down the progression of these devastating conditions.